This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bender, M A Articles by Miller, A D Search for Related Content PubMed PubMed Citation Articles by Bender, M A Articles by Miller, A D

 Previous Article  |  Next Article 

Mol Cell Biol. 1989 April; 9(4): 1426-1434

A majority of mice show long-term expression of a human beta-globin gene after retrovirus transfer into hematopoietic stem cells.

Department of Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.

ABSTRACT

Murine bone marrow was infected with a high-titer retrovirus vector containing the human beta-globin and neomycin phosphotransferase genes. Anemic W/Wv mice were transplanted with infected marrow which in some cases had been exposed to the selective agent G418. Human beta-globin expression was monitored in transplanted animals by using a monoclonal antibody specific for human beta-globin polypeptide, and hematopoietic reconstitution was monitored by using donor and recipient mice which differed in hemoglobin type. In some experiments all transplanted mice expressed the human beta-globin polypeptide for over 4 months, and up to 50% of peripheral erythrocytes contained detectable levels of polypeptide. DNA analysis of transplanted animals revealed that virtually every myeloid cell contained a provirus. Integration site analysis and reconstitution of secondary marrow recipients suggested that every mouse was reconstituted with at least one infected stem cell which had extensive repopulation capability. The ability to consistently transfer an active beta-globin gene into mouse hematopoietic cells improves the feasibility of using these techniques for somatic cell gene therapy in humans.

This article has been cited by other articles:

• Moi, P., Sadelain, M. (2008). Towards the genetic treatment of {beta}-thalassemia: new disease models, new vectors, new cells. haematol 93: 325-330 [Full Text]  
• Malik, P., Arumugam, P. I. (2005). Gene Therapy for {beta}-Thalassemia. ASH Education Book 2005: 45-50 [Abstract] [Full Text]  
• May, C., Rivella, S., Chadburn, A., Sadelain, M. (2002). Successful treatment of murine beta -thalassemia intermedia by transfer of the human beta -globin gene. Blood 99: 1902-1908 [Abstract] [Full Text]  
• BOHL, D., HEARD, J.-M. (2000). Delivering Erythropoietin through Genetically Engineered Cells. J. Am. Soc. Nephrol. 11: 159S-162 [Abstract] [Full Text]  
• Klug, C. A., Cheshier, S., Weissman, I. L. (2000). Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny. Blood 96: 894-901 [Abstract] [Full Text]  
• Persons, D. A., Nienhuis, A. W. (2000). Gene therapy for the hemoglobin disorders: Past, present, and future. Proc. Natl. Acad. Sci. USA 97: 5022-5024 [Full Text]  
• Raftopoulos, H., Ward, M., Leboulch, P., Bank, A. (1997). Long-Term Transfer and Expression of the Human beta -Globin Gene in a Mouse Transplant Model. Blood 90: 3414-3422 [Abstract] [Full Text]  
• Havenga, M., Hoogerbrugge, P., Valerio, D., van Es, H. H.G. (1997). Retroviral Stem Cell Gene Therapy. Stem Cells 15: 162-179 [Abstract] [Full Text]  
• Mulligan, R. (1993). The basic science of gene therapy. Science 260: 926-932 [Abstract]  
• Ferrari, G, Rossini, S, Giavazzi, R, Maggioni, D, Nobili, N, Soldati, M, Ungers, G, Mavilio, F, Gilboa, E, Bordignon, C (1991). An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. Science 251: 1363-1366 [Abstract]  
• Temin, H. (1989). Retrovirus vectors: promise and reality. Science 246: 983-983  
• Sabatino, D. E., Seidel, N. E., Aviles-Mendoza, G. J., Cline, A. P., Anderson, S. M., Gallagher, P. G., Bodine, D. M. (2000). Long-term expression of gamma -globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma -globin gene fused to the ankyrin-1 promoter. Proc. Natl. Acad. Sci. USA 97: 13294-13299 [Abstract] [Full Text]